SYNE2, spectrin repeat containing nuclear envelope protein 2, 23224
N. diseases: 91; N. variants: 23
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.080 | 14 | 64214130 | intron variant | A/C;G;T | snv |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.800 | 1.000 | 2 | 2012 | 2017 | ||||||||
|
1.000 | 14 | 64210033 | missense variant | C/G;T | snv | 4.0E-06; 4.8E-03 |
|
0.800 | 1.000 | 1 | 2007 | 2007 | |||||||||
|
1.000 | 0.080 | 14 | 64213242 | intron variant | A/G | snv | 0.63 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.700 | 1.000 | 2 | 2018 | 2018 | |||||||
|
14 | 63923312 | intron variant | G/C | snv | 0.68 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
1.000 | 0.080 | 14 | 63773159 | intron variant | -/ATTT | delins | 0.24 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.080 | 14 | 63773159 | intron variant | -/ATTT | delins | 0.24 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.080 | 14 | 63773159 | intron variant | -/ATTT | delins | 0.24 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.080 | 14 | 63773159 | intron variant | -/ATTT | delins | 0.24 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
14 | 63772633 | intron variant | T/C | snv | 0.20 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
14 | 63772633 | intron variant | T/C | snv | 0.20 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
14 | 64160241 | intron variant | C/T | snv | 1.6E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 0.040 | 14 | 63864705 | intron variant | T/C | snv | 0.81 |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.882 | 0.080 | 14 | 63942595 | intron variant | G/A | snv | 0.68 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.882 | 0.080 | 14 | 63942595 | intron variant | G/A | snv | 0.68 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.882 | 0.080 | 14 | 63942595 | intron variant | G/A | snv | 0.68 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
14 | 64226667 | intron variant | G/A | snv | 0.25 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 0.040 | 14 | 64093374 | stop gained | G/A | snv | 8.5E-02 | 8.9E-02 |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | ||||||
|
14 | 63768838 | intron variant | G/T | snv | 0.24 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||||
|
14 | 63768838 | intron variant | G/T | snv | 0.24 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
1.000 | 0.080 | 14 | 63765502 | intron variant | G/A | snv | 0.23 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.080 | 14 | 63765502 | intron variant | G/A | snv | 0.23 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
14 | 63766999 | intron variant | A/G | snv | 0.23 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
14 | 63766999 | intron variant | A/G | snv | 0.23 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
1.000 | 0.080 | 14 | 63767002 | intron variant | A/T | snv | 0.23 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.080 | 14 | 63767002 | intron variant | A/T | snv | 0.23 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 |